INFECTIOUS DISEASES
University of Alabama at Birmingham
Birmingham, Estados UnidosPublications in collaboration with researchers from University of Alabama at Birmingham (1)
2023
-
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
The Lancet, Vol. 401, Núm. 10370, pp. 49-59